← Back to Clinical Trials
Recruiting NCT06579599

NCT06579599 Study on the Preventive Effect of Establishing an Integrated Working Group of Doctors and Nurses in Operating Room

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06579599
Status Recruiting
Phase —
Sponsor The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Condition Orthopedic Disorder
Study Type INTERVENTIONAL
Enrollment 130 participants
Start Date 2024-12-30
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
an integrated working group nursing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 130 participants in total. It began in 2024-12-30 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To explore the preventive effect and clinical enlightenment of establishing an integrated working group of doctors and nurses in operating room on incision infection in orthopedic surgery.

Eligibility Criteria

Inclusion Criteria: * (1) All selected cases met the relevant diagnostic criteria outlined in the orthopedic disease guidelines. Diagnosis was confirmed through imaging methods. (2) The patients ranged in age from 18 to 70. (3) All individuals underwent surgery in the orthopedic department of our hospital. (4) The vital signs of the patients were essentially stable. (5) Patients possessed normal cognitive function before the operation and demonstrated the ability to listen, speak, read, and write. Exclusion Criteria: * (1) Orthopedic patients with multiple injuries in other locations (such as craniocerebral trauma, chest trauma, etc.); (2) Patients with severe internal diseases, such as severe anemia, severe diabetes, liver insufficiency; (3) Patients with chronic infectious diseases; (4) Patients with malignant tumor; (5) Patients with pathological fracture, such as bone tumor; (6) Patients with mental diseases and cognitive impairment.

Contact & Investigator

Central Contact

Feng Huang, BA

✉ 3220001@zju.edu.cn

📞 18758871337

Principal Investigator

Feng Huang, BA

PRINCIPAL INVESTIGATOR

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Frequently Asked Questions

Who can join the NCT06579599 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Orthopedic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06579599 currently recruiting?

Yes, NCT06579599 is actively recruiting participants. Contact the research team at 3220001@zju.edu.cn for enrollment information.

Where is the NCT06579599 trial being conducted?

This trial is being conducted at Yiwu, China.

Who is sponsoring the NCT06579599 clinical trial?

NCT06579599 is sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. The principal investigator is Feng Huang, BA at The Fourth Affiliated Hospital of Zhejiang University School of Medicine. The trial plans to enroll 130 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology